Contemporary Quality of Life Issues Affecting Gynecologic Cancer Survivors

Por Carter, Jeanne, Penson, Richard, Barakat, Richard, Wenzel, Lari
Publicado no Hematol Oncol Clin North Am (2011)

Connection: Schwartz Center Rounds at Massachusetts General Hospital Cancer Center

Por Penson, Richard T., Schapira, Lidia, Mack, Sally, Stanzler, Marjorie, Lynch, Thomas J.
Publicado em 2010

The bioavailability and pharmacokinetics of subcutaneous, nebulized and oral morphine-6-glucuronide

Por Penson, Richard T, Joel, Simon P, Roberts, Michael, Gloyne, Anna, Beckwith, Stephen, Slevin, Maurice L
Publicado em 2002

Rapid Development of Hypertension and Proteinuria with Cediranib, an Oral Vascular Endothelial Growth Factor Receptor Inhibitor

Por Robinson, Emily S., Matulonis, Ursula A., Ivy, Percy, Berlin, Suzanne T., Tyburski, Karin, Penson, Richard T., Humphreys, Benjamin D.
Publicado em 2010

Randomized phase II study of the PDGFRα antibody olaratumab plus liposomal doxorubicin versus liposomal doxorubicin alone in patients with platinum-refractory or platinum-resistant...

Por McGuire, William P., Penson, Richard T., Gore, Martin, Herraez, Antonio Casado, Peterson, Patrick, Shahir, Ashwin, Ilaria, Robert
Publicado no BMC Cancer (2018)

Caring for One of Our Own

Por Schapira, Lidia, Blaszkowsky, Lawrence S., Cashavelly, Barbara J., Kim, Christina Y., Riley, John P., Wold, Mali C., Ryan, David P., Penson, Richard T.
Publicado em 2014

A Phase II Evaluation of Belinostat and Carboplatin in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma: A Gynec...

Por Dizon, Don S., Blessing, John A., Penson, Richard T., Drake, Richard D., Walker, Joan L., Johnston, Carolyn M., DiSilvestro, Paul A., Fader, Amanda Nickles
Publicado em 2012

Ascites analysis by a microfluidic chip allows tumor-cell profiling

Por Peterson, Vanessa M., Castro, Cesar M., Chung, Jaehoon, Miller, Nathan C., Ullal, Adeeti V., Castano, Maria D., Penson, Richard T., Lee, Hakho, Birrer, Michael J., Weissleder, Ralph
Publicado em 2013

Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian Carcinoma

Por Horowitz, Neil S., Penson, Richard T., Duda, Dan G., di Tomaso, Emmanuelle, Boucher, Yves, Ancukiewicz, Marek, Cohen, Kenneth S., Berlin, Suzanne, Krasner, Carolyn N., Moses, Marsha A., Jain, Rakesh K.
Publicado em 2011

Recommended Patient-Reported Core Set of Symptoms and Quality-of-Life Domains to Measure in Ovarian Cancer Treatment Trials

Por Donovan, Kristine A., Donovan, Heidi S., Cella, David, Gaines, Martha E., Penson, Richard T., Plaxe, Steven C., von Gruenigen, Vivian E., Bruner, Deborah Watkins, Reeve, Bryce B., Wenzel, Lari
Publicado em 2014

The Feasibility and Effects of Acupuncture on Quality of Life Scores During Chemotherapy in Ovarian Cancer: Results from a Pilot, Randomized Sham-Controlled Trial

Por Lu, Weidong, Matulonis, Ursula A., Dunn, Julie E., Lee, Hang, Doherty-Gilman, Anne, Dean-Clower, Elizabeth, Goodman, Annekathryn, Davis, Roger B., Buring, Julie, Wayne, Peter, Rosenthal, David S., Penson, Richard T.
Publicado em 2012

Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group Study

Por Seamon, Leigh G, Java, James J, Monk, Bradley J, Penson, Richard T, Brown, Jubilee, Mannel, Robert S, Oaknin, Anna, Leitao, Mario M, Eisenhauer, Eric L, Long, Harry J, Liao, Shu Y, Tewari, Krishnansu S
Publicado no Br J Cancer (2018)

Acupuncture for Chemotherapy-Induced Neutropenia in Patients with Gynecologic Malignancies: A Pilot Randomized, Sham-Controlled Clinical Trial

Por Lu, Weidong, Matulonis, Ursula A., Doherty-Gilman, Anne, Lee, Hang, Dean-Clower, Elizabeth, Rosulek, Andrew, Gibson, Carolyn, Goodman, Annekathryn, Davis, Roger B., Buring, Julie E., Wayne, Peter M., Rosenthal, David S., Penson, Richard T.
Publicado em 2009

Improved Survival with Bevacizumab in Advanced Cervical Cancer

Por Tewari, Krishnansu S., Sill, Michael W., Long, Harry J., Penson, Richard T., Huang, Helen, Ramondetta, Lois M., Landrum, Lisa M., Oaknin, Ana, Reid, Thomas J., Leitao, Mario M., Michael, Helen E., Monk, Bradley J.
Publicado em 2014

Prospective Validation of Pooled Prognostic Factors in Women with Advanced Cervical Cancer Treated with Chemotherapy with/without Bevacizumab: NRG Oncology/GOG Study

Por Tewari, Krishnansu S., Sill, Michael W., Monk, Bradley J., Penson, Richard T., Long, Harry J., Poveda, Andrés, Landrum, Lisa M., Leitao, Mario M., Brown, Jubilee, Reid, Thomas J.A., Michael, Helen E., Moore, David H.
Publicado no Clin Cancer Res (2015)

A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal can...

Por Bell-McGuinn, Katherine M., Matthews, Carolyn M., Ho, Steffan N., Barve, Minal, Gilbert, Lucy, Penson, Richard T., Lengyel, Ernst, Palaparthy, Rameshraja, Gilder, Kye, Vassos, Artemios, McAuliffe, William, Weymer, Sara, Barton, Jeremy, Schilder, Russell J.
Publicado no Gynecol Oncol (2011)

Patient Reported Outcomes in a Practice Changing Randomized Trial of Bevacizumab in the Treatment of Advanced Cervical Cancer: An NRG Oncology/Gynecologic Oncology Group Study

Por Penson, Richard T., Huang, Helen Q., Wenzel, Lari B., Monk, Bradley J., Stockman, Sharon, Long, Harry J., Ramondetta, Lois M., Landrum, Lisa M., Oaknin, Ana, Reid, Thomas J.A., Leitao, Mario M., Method, Michael, Michael, Helen, Tewari, Krishnansu S.
Publicado no Lancet Oncol (2015)

Cediranib, an Oral Inhibitor of Vascular Endothelial Growth Factor Receptor Kinases, Is an Active Drug in Recurrent Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer

Por Matulonis, Ursula A., Berlin, Suzanne, Ivy, Percy, Tyburski, Karin, Krasner, Carolyn, Zarwan, Corrine, Berkenblit, Anna, Campos, Susana, Horowitz, Neil, Cannistra, Stephen A., Lee, Hang, Lee, Julie, Roche, Maria, Hill, Margaret, Whalen, Christin, Sullivan, Laura, Tran, Chau, Humphreys, Benjamin D., Penson, Richard T.
Publicado em 2009

A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma(,)

Por Penson, Richard T., Moore, Kathleen M., Fleming, Gini F., Braly, Patricia, Schimp, Veronica, Nguyen, Hoa, Matulonis, Ursula A., Banerjee, Susana, Haluska, Paul, Gore, Martin, Bodurka, Diane C., Hozak, Rebecca R., Joshi, Adarsh, Xu, Yihuan, Schwartz, Jonathan D., McGuire, William P.
Publicado no Gynecol Oncol (2014)

Final Overall Survival of the Phase III Randomised Trial of Chemotherapy with and without Bevacizumab for Advanced Cervical Cancer: An NRG Oncology/Gynecologic Oncology Group Study

Por Tewari, Krishnansu S., Sill, Michael W., Penson, Richard T., Huang, Helen, Ramondetta, Lois M., Landrum, Lisa M., Oaknin, Ana, Reid, Thomas J., Leitao, Mario M., Michael, Helen E., DiSaia, Philip J., Copeland, Larry J., Creasman, William T., Stehman, Frederick B., Brady, Mark F., Burger, Robert A., Thigpen, J. Tate, Birrer, Michael J., Waggoner, Steven E., Moore, David H., Look, Katherine Y., Koh, Wui-Jin, Monk, Bradley J.
Publicado no Lancet (2017)